Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor. Br J Haematol 1991 Jul;78(3):460-3
Date
07/01/1991Pubmed ID
1873233DOI
10.1111/j.1365-2141.1991.tb04468.xScopus ID
2-s2.0-0025797762 (requires institutional sign-in at Scopus site) 19 CitationsAuthor List
Schmidt ML, Smith HE, Gamerman S, DiMichele D, Glazer S, Scott JPAuthor
John Paul Scott MD Emeritus Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
ChildCompartment Syndromes
Drug Administration Schedule
Factor IX
Factor VIIa
Hemophilia B
Hemorrhage
Humans
Immunoglobulin G
Male
Recombinant Proteins
